Roy AM - Search Results

1

Effect of Neighborhood Deprivation Index on Breast Cancer Survival in the United States.

Roy AM, George A, Attwood K, Alaklabi S, Patel A, Omilian AR, Yao S, Gandhi S. Roy AM, et al. Res Sq [Preprint]. 2023 Apr 7:rs.3.rs-2763010. doi: 10.21203/rs.3.rs-2763010/v1. Res Sq. 2023. Update in: Breast Cancer Res Treat. 2023 Nov;202(1):139-153. doi: 10.1007/s10549-023-07053-4 PMID: 37066175 Free PMC article. Updated. Preprint.

2

Systemic Therapy De-Escalation in Early-Stage Triple-Negative Breast Cancer: Dawn of a New Era?

Gupta RK, Roy AM, Gupta A, Takabe K, Dhakal A, Opyrchal M, Kalinski P, Gandhi S. Gupta RK, et al. Among authors: roy am. Cancers (Basel). 2022 Apr 7;14(8):1856. doi: 10.3390/cancers14081856. Cancers (Basel). 2022. PMID: 35454764 Free PMC article. Review.

3

A review of treatment options in HER2-low breast cancer and proposed treatment sequencing algorithm.

Roy AM, Kumarasamy VM, Dhakal A, O'Regan R, Gandhi S. Roy AM, et al. Cancer. 2023 Sep 15;129(18):2773-2788. doi: 10.1002/cncr.34904. Epub 2023 Jun 22. Cancer. 2023. PMID: 37349954 Free PMC article. Review.

4

Association between Environmental Temperature and Survival in Gastroesophageal Cancers: A Population Based Study.

Gupta K, George A, Attwood K, Gupta A, Roy AM, Gandhi S, Siromoni B, Singh A, Repasky E, Mukherjee S. Gupta K, et al. Among authors: roy am. Cancers (Basel). 2023 Dec 22;16(1):74. doi: 10.3390/cancers16010074. Cancers (Basel). 2023. PMID: 38201502 Free PMC article.

5

Facing the conundrum: which first-line therapy should be used for patients with metastatic triple-negative breast cancer carrying germline BRCA mutation?

Alaklabi S, Roy AM, Chaudhary LN, Gandhi S. Alaklabi S, et al. Among authors: roy am. Explor Target Antitumor Ther. 2023;4(6):1301-1309. doi: 10.37349/etat.2023.00198. Epub 2023 Dec 27. Explor Target Antitumor Ther. 2023. PMID: 38213539 Free PMC article. Review.

6

Real-World Clinical Outcomes With Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.

Alaklabi S, Roy AM, Zagami P, Chakraborty A, Held N, Elijah J, George A, Attwood K, Shaikh SS, Chaudhary LN, Abdou Y, Gandhi S. Alaklabi S, et al. Among authors: roy am. JCO Oncol Pract. 2024 Oct 1:OP2400242. doi: 10.1200/OP.24.00242. Online ahead of print. JCO Oncol Pract. 2024. PMID: 39353151

7

Breast biomarkers evolution between primary and distant metastasis: incidence and significance.

Khedr M, Gandhi S, Roy AM, Alharbi M, George A, Attwood K, Khoury T. Khedr M, et al. Among authors: roy am. Histopathology. 2024 Dec 17. doi: 10.1111/his.15387. Online ahead of print. Histopathology. 2024. PMID: 39687980

8

A comparative study of cancer drug approvals in india and high-income countries.

Roy AM, Jones R, Mathew A. Roy AM, et al. J Cancer Policy. 2022 Sep;33:100349. doi: 10.1016/j.jcpo.2022.100349. Epub 2022 Jul 25. J Cancer Policy. 2022. PMID: 35902067

9

Management of immune-mediated toxicities and their implications in the outcomes of advanced kidney cancer.

Roy AM, George S. Roy AM, et al. Immunotherapy. 2023 Apr;15(6):397-400. doi: 10.2217/imt-2023-0010. Epub 2023 Mar 2. Immunotherapy. 2023. PMID: 36861344

10

Alpelisib-Induced Diabetic Ketoacidosis in a Non-diabetic Patient.

Fugere T, Roy AM, Makhoul I. Fugere T, et al. Among authors: roy am. Cureus. 2021 Nov 5;13(11):e19295. doi: 10.7759/cureus.19295. eCollection 2021 Nov. Cureus. 2021. PMID: 34900474 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters